Chemomab Therapeutics Ltd. Restructuring Charges
Chemomab Therapeutics Ltd. (CMMB) reported Restructuring Charges of $749.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2021-03-09
- Chemomab Therapeutics Ltd. restructuring charges for the quarter ending 2020-12-31 was $0.00.
- Chemomab Therapeutics Ltd. restructuring charges for the quarter ending 2020-09-30 was $79.00K.
- Chemomab Therapeutics Ltd. restructuring charges for the quarter ending 2020-06-30 was $0.00.
- Chemomab Therapeutics Ltd. restructuring charges for the quarter ending 2020-03-31 was $670.00K.
- Chemomab Therapeutics Ltd. restructuring charges for fiscal 2020 was $749.00K, a 77.64% decline from fiscal 2019.
- Chemomab Therapeutics Ltd. restructuring charges for fiscal 2019 was $3.35M.
| Period end | Restructuring Charges 1 month | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $79.00K derived: sum of 2 quarters · filed 2021-03-09 | $79.00K derived: sum of 3 quarters · filed 2021-03-09 | $749.00K 10-K · filed 2021-03-09 | |
| 2020-09-30 | $79.00K 10-Q · filed 2020-11-16 | $79.00K derived: sum of 2 quarters · filed 2020-11-16 | $749.00K 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $670.00K 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | $670.00K 10-Q · filed 2020-05-07 | ||||
| 2020-01-31 | $247.00K 10-Q · filed 2020-05-07 | ||||
| 2019-12-31 | $3.35M 10-K · filed 2021-03-09 | ||||
| 2018-01-31 | $247.00K 10-Q · filed 2020-11-16 |